Lahesjok AE, Koslaniemi M., Pandolfo M., et al: Linkage studies in progressive myoclonus epilepsy: Unverricht-Lundborg and Lafora's diseases. Neurology1992;42:1545-1550.
Dreifuss FE: Treatment of seizure disorders and myoclonus. Psychosomatics1985;26:30-37.
4.
McKee PJW , McGinn G., Larkin JG, Brodie MJ: Myoclonic epilepsy—Pitfalls in diagnosis and management. Scott Med J1991 ;36:18-19.
5.
Somerville ER , Olanow W.: Valproic acid, treatment of myoclonus in dyssynergia cerebellaris myoclonica. Arch Neurol1982;39:527-528.
6.
Iivanainen M. , Himberg JJ: Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy. Arch Neurol1982;39:236-238.
7.
Bartholini G. : GABA receptor agonist: Pharmacological spectrum and therapeutic actions. Med Res Rev1985;5:55-75.
8.
Ryan DM, Blumenthal FS: Baclofen-induced dyskinesia. Arch Phys Med Rehabil1993;74:766-767.
9.
Siegfried RN , Jacobson L., Chabal C.: Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity . Anesthesiology1992;77: 1048-1050.
10.
Ohisalo JJ, Murros K., Fredholm BB, et al: Concentration of gamma-aminobutyric acid and adenosine in the CSF in progressive myoclonus epilepsy without Lafora's bodies. Arch Neurol1983;40:623-625.
11.
Airaksinen EM, Leino E.: Decrease of GABA in the cerebrospinal fluid of patients with progressive myoclonus epilepsy and its correlation with the decrease of 5HIAA and HVA. Acta Neurol Scand1982;66:666-672.
12.
Smith CR, LaRocca NG, Giesser BS, et al: High-dose oral baclofen: Experience in patients with multiple sclerosis. Neurology1991;41:1829-1831.
13.
Menon MK, Vivonia CA: Serotonergic drugs, benzodiazepines and baclofen block muscimol-induced myoclonic jerks in a strain of mice. Eur J Pharmacol1981;73:155-161.
14.
Coletti A., Mandelli A., Minoli G., et al: Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and gabaergic drugs. J Neurol1980;223:67-70.
